Pharmaceutical
| Mon 29 Jun 2026
Beijing, June 30 -- Novartis has filed a patent application for Compounds and Compositions for Modulating ERK Activity. This invention was developed by Hussey Michael J, Sendzik Martin, Mo Rubin, Ku Nig Roland, Ramage Michael J, Larrow James F, Pfister Keith Bruce, Skepper Christopher Keith, Moebitz Henrik, Baum Erich W, Zecri F..